Mielóma multiplex: vizsgálatok itt: Franciaország
91 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
- Where
- Lille Cedex, Nantes, Poitiers, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 165 worldwide
- Run by
- K36 Therapeutics, Inc.
See details and how to joinNCT05651932 · EU 2022-500801-41-00 - 3. fázisNot yet taking people in FranciaországA Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
- Where
- Lille, Nantes, Paris, Toulouse
- Életkor
- 18 év to 130 év
- People
- 750 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07735637 - 1. fázisFut, nem toborozA Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Nantes, Paris, Poitiers
- Életkor
- 18 év and over
- People
- 186 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT04910568 · EU 2023-507019-36-00 - 3. fázisTaking peopleA Phase 3 Randomized Study Comparing JNJ-79635322 versus Teclistamab in Participants with Relapsed or Refractory Multiple Myeloma
- Where
- Amiens Cedex 1, Lille, Montpellier Cedex 5, Nantes, Pessac, Pierre-Bénite, Poitiers, Toulouse Cedex 9, Tours, Villejuif
- Életkor
- 18 év and over
- People
- 206 worldwide
- Run by
- Janssen Cilag International
See details and how to join2025-523815-12-00 - 2/3. fázisFut, nem toborozA Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
- Where
- Caen Cedex 9, Dunkirk Cedex 1, Epagny Metz-tessy, Lille, Montpellier Cedex 5, Nantes, Paris, Pessac, Pierre-Bénite, Poitiers, Saint-Priest-en-Jarez, Toulouse Cedex 9, Tours, Vannes
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- AbbVie
See details and how to joinNCT07095452 · EU 2025-520897-21-00 - 2. fázisCsak meghívásosInternational Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
- Where
- Nantes
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Sanofi
See details and how to joinNCT05669989 - 3. fázisTaking peopleA Phase 3 Study Comparing Ramantamig plus Daratumumab Versus DVRd or DRd in Participants With NDMM for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
- Where
- Lille, Marseille, Montpellier Cedex 5, Nancy Cedex, Nantes, Paris, Pessac, Pierre-Bénite, Poitiers, Saint-Cloud, Toulouse Cedex 9, Tours
- Életkor
- 18 év and over
- People
- 423 worldwide
- Run by
- Janssen Cilag International
See details and how to join2026-526654-14-01 - 3. fázisNot yet taking people in FranciaországSingle-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Where
- Angers, La Roche-sur-Yon, Nantes, Rennes, Rouen
- Életkor
- 18 év and over
- People
- 63 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07648264 · EU 2026-525626-38-00 - 3. fázisNot yet taking people in FranciaországA trial to learn how well AZD0120 works and about its safety in adults with transplant eligible newly diagnosed multiple myeloma.
- Where
- Lille, Nantes, Paris, Paris Cedex 12, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 249 worldwide
- Run by
- AstraZeneca AB
See details and how to join2026-525367-40-00 - 1/2. fázisNot yet taking people in FranciaországA Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma
- Where
- Amiens Cedex 1, Angers, Argenteuil Cedex, Bayonne, Bordeaux, Brest, Caen Cedex 9, Clermont-Ferrand, Dijon, Epagny Metz-tessy, Grenoble Cedex 9, Le Mans Cedex 9, Lille Cedex, Limoges, Nancy, Nantes, Nantes Cedex 2, Nice, Orleans Cedex 2, Paris, Paris Cedex 12, Paris Cedex 13, Pierre-Bénite, Poitiers, Rouen Cedex, Saint-Etienne, Strasbourg, Toulouse Cedex 9, Tours Cedex 9
- Életkor
- 18 év and over
- People
- 44
- Run by
- Centre Hospitalier Universitaire de Saint Etienne
See details and how to joinNCT07612787 · EU 2025-520976-25-00 - 3. fázisNot yet taking people in FranciaországA Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Where
- Brest, Nantes Cedex 2, Tours
- Életkor
- 18 év and over
- People
- 49 worldwide
- Run by
- Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00 - No phaseNot yet taking people in FranciaországImmunomonitoring and Predictive Biomarkers After CAR-T Cell Therapy in B-Cell Lymphoma and Multiple Myeloma
- Where
- Rouen
- Életkor
- 18 év and over
- People
- 45
- Run by
- Centre Henri Becquerel
See details and how to joinNCT07852377 - 3. fázisTaking peopleElranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients
- Where
- Amiens Cedex 1, Angers, Argenteuil Cedex, Avignon Cedex 9, Bayonne, Besançon, Blois Cedex, Bobigny Cedex, Bourg En Bresse, Brest, Caen, Chalon Sur Saone Cedex, Chambéry, Clamart, Clermont-Ferrand, Corbeil-Essonnes, Creteil, Dijon, Dunkirk Cedex 1, Epagny Metz-tessy, Grenoble Cedex 9, La Roche Sur Yon Cedex 9, Le Chesnay Rocquencourt, Le Coudray, Le Mans Cedex 9, Lille Cedex, Limoges Cedex 1, Lyon, Meaux, Metz Cedex 03, Mont-De-Marsan Cedex, Montivilliers, Montpellier Cedex 5, Mulhouse, Nantes, Nice, Nimes Cedex 9, Orleans Cedex 2, Paris, Périgueux, Perpignan Cedex, Pessac, Pierre-Bénite, Poitiers, Pontoise, Quimper Cedex, Reims Cedex, Rennes, Rouen, Saint-Brieuc, Saint-Denis, Saint-Priest-en-Jarez, Saint-Quentin, Strasbourg Cedex 2, Tarbes Cedex 9, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy, Vannes, Villejuif
- Életkor
- 18 év to 69 év
- People
- 824 worldwide
- Run by
- Intergroupe Francophone du Myelome
See details and how to joinNCT06918002 · EU 2024-516418-39-00 - 3. fázisNot yet taking people in FranciaországA Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
- Where
- Lille, Nantes, Paris, Pierre-Bénite, Poitiers, Toulouse
- Életkor
- 18 év and over
- People
- 508 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07391657 - 3. fázisTaking peopleA Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Amiens, Lyon, Montpellier, Nantes, Poitiers, Talence, Toulouse, Tours
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07518186 - 2. fázisTaking peopleFaecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
- Where
- Amiens, Angers, Besançon, Clermont-Ferrand, Grenoble, Lille, Limoges, Lyon, Nancy, Nantes, Nice, Paris, Pessac, Poitiers, Rouen, Saint-Etienne, Toulouse
- Életkor
- 18 év and over
- People
- 150
- Run by
- University Hospital, Clermont-Ferrand
See details and how to joinNCT04935684 - No phaseTaking peopleComparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma
- Where
- Saint-Etienne
- Életkor
- 18 év and over
- People
- 36
- Run by
- Centre Hospitalier Universitaire de Saint Etienne
See details and how to joinNCT06474182 · EU 2024-515329-27-00 - 2. fázisTaking peoplePhase 2 Randomized, Double-blind, Placebo-controlled Study of Prophylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma
- Where
- Argenteuil Cedex, Bayonne, Grenoble Cedex 9, Le Mans Cedex 9, Nantes, Quimper Cedex
- Életkor
- 18 év and over
- People
- 123 worldwide
- Run by
- Janssen Cilag International
See details and how to join2025-524793-42-00 - 3. fázisNot yet taking people in FranciaországA trial to learn how well AZD0120 works and about its safety in adults with newly diagnosed multiple myeloma
- Where
- Lille, Nantes, Paris, Poitiers, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 234 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-524014-29-00 - No phaseTaking peopleRAT-HEMATO : Return to Work After Malignant Hemopathy
- Where
- Angers, Brest, Caen, Cholet, Montivilliers, Morlaix, Rennes, Rouen, Tours
- Életkor
- 18 év to 55 év
- People
- 264
- Run by
- University Hospital, Angers
See details and how to joinNCT06262789 - No phaseTaking peopleA Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
- Where
- Lille, Marseille, Nantes, Paris, Toulouse, Vandœuvre-lès-Nancy
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Janssen-Cilag Ltd.
See details and how to joinNCT06285318 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
- Where
- Dunkirk Cedex 1, Nantes, Paris, Saint-Priest-en-Jarez
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07227311 · EU 2025-523117-28-00 - 3. fázisFut, nem toborozA Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- Where
- Lille Cedex, Limoges Cedex 1, Nantes, Paris, Paris Cedex 12, Pierre-Bénite, Poitiers, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 893 worldwide
- Run by
- Pfizer
See details and how to joinNCT05020236 · EU 2023-509208-14-00 - 3. fázisNot yet taking people in FranciaországStudy of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
- Where
- Lille, Nantes, Paris, Poitiers, Toulouse
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07764978 - 3. fázisTaking peopleA trial to learn how well AZD0120 works and how safe it is in people with relapsed or refractory multiple myeloma.
- Where
- Lille Cedex, Nantes, Paris, Pierre-Bénite, Poitiers, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 153 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-523285-25-00